Prof. Dr. Sebastian Kobold Ludwig-Maximilians-Universität München, Germany

Dr. Kobold studied medicine in Homburg (D), Zurich (CH) and Bordeaux (F). He completed his doctoral training in tumor immunology with C. Renner in Zurich and Homburg. Dr. Kobold did his residency training in hematology, oncology and clinical pharmacology in Hamburg and Munich. Since 2014 Dr. Kobold is a board... read morecertified clinical pharmacologist and immunologist and serves as attending physician at the university hospital of the LMU. Dr. Kobold trained as a post doctoral fellow in Hamburg (D. Atanackovic), Munich (S. Endres) and Boston (K. Wucherpfennig). In 2019 he was appointed Professor of Medicine and Experimental Immunooncology at the LMU Munich and as deputy director of the division of clinical pharmacology at the University hospital of the LMU. The research of Prof. Kobold is focussed on developing innovative immunotherapeutic strategies utilizing T cells for cancer treatment. His research has been internationally recognized with among others the Ernst-Jung Career Advancement Award, the Vincenz Czerny Award for cancer research, the Johann-Georg-Zimmermann Award for cancer research and more recently the Wilhelm Vaillant Price for Medical Research. Dr. Kobold also serves as senior academic editor to the Journal for the Immunotherapy of Cancer and the European Journal of Cancer and reviews for international leading journals and grant funders including the Nature and Science publishing groups.